Article
Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.
Pharmacogenomics - 1 Mar 2013
Umićević Mirkov Maša, Coenen Marieke J H
Abstract excerpt
Rheumatoid arthritis is a disease showing considerable heterogeneity in all its aspects, including response to therapy. The efficacy of disease-modifying antirheumatic drugs (DMARDs), with or without biological activity, has been unambiguously established. DMARDs improve the symptoms associated with the disease, and, even more importantly, are capable of stagnating the joint damage associated with the disease....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.